Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01140477 · ClinicalTrials.gov registry record · NA

Toric Intraocular Lens Following Cataract Surgery

A NA study, sponsored by Bausch & Lomb Incorporated.

Completed
Registry status
NA
Development phase
229
Enrollment target

NCT01140477 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 229 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01140477, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.

COMPLETED
Registry status
NA
Development phase
229 participants
Enrollment target

Study Summary

The objective of this clinical trial is to evaluate the safety and effectiveness of the Bausch + Lomb Toric Accommodating Posterior Chamber Silicone Intraocular Lens used to provide near, intermediate, and distance vision and a reduction of the effects of preoperative corneal astigmatism in presbyopic patients undergoing cataract extraction and intraocular lens (IOL) placement.

Interventions

  • DEVICE Toric Accommodating Lens
  • DEVICE Accommodating Lens

Trial Details

FieldValue
Enrollment Target 229 participants
Start Date 2010-06
Est. Completion 2012-10
Phase NA

Sponsor

Bausch & Lomb Incorporated

174 total trials

What the Registry Record Tells You About NCT01140477

The ClinicalTrials.gov registry entry for NCT01140477 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Toric Accommodating Lens is the first listed.

NCT01140477 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01140477 about?

NCT01140477 is a clinical study titled "Toric Intraocular Lens Following Cataract Surgery". The objective of this clinical trial is to evaluate the safety and effectiveness of the Bausch + Lomb Toric Accommodating Posterior Chamber Silicone Intraocular Lens used to provide near, intermediate, and distance vision and a reduction of the effects of preoperative corneal astigmatism in presbyop...

What is the current status of trial NCT01140477?

This trial is currently completed. It is a NA study. The enrollment target is 229 participants. The study started on 2010-06. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01140477?

The interventions under investigation include: Toric Accommodating Lens (DEVICE), Accommodating Lens (DEVICE).

Who is sponsoring clinical trial NCT01140477?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.